DHR beats Q2 estimates as Life Sciences posts its strongest quarter in years, prompting the company to raise its 2026 ...

Wave Life Sciences has seen its share price fall 64.0% year to date, yet the valuation checks suggest the stock still screens as expensive rather than a clear bargain. Wave Life Sciences is down 64.0% ...

Gov. Josh Shapiro visited a University City life sciences incubator on Tuesday to celebrate a new $125 million fund aimed at ...

Caris Life Sciences proprietary WES/WTS/WGS technology and massive data advantage underpin its leadership in oncology ...

Large language models (LLMs) are gradually transforming research in the life sciences in ways that extend far beyond ...

A ccording to the CBRE U.S. Life Sciences Outlook 2025 report, U.S life sciences employment hit a record high in 2024, and more job growth is expected in 2025. Meanwhile, the life sciences sector ...

BMS enhances its AI computing power as big pharma race to stay competitive within the shifting global landscape.

Life sciences businesses are very healthy these days. Advances in research, testing, and manufacturing in the pharmaceutical, biotech, medical devices, and related industries continue to generate high ...

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and ...

In this week’s edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear’s move into healthcare, Harrison.ai’s U.S. expansion, and more. To get it in your inbox, ...

Premas Life Sciences and Uncoded participated in GENE-SIGHT 2026, where experts discussed genetics-enabled glaucoma care, precision medicine, early diagnosis, clinical collaboration and policy ...

Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and ...